794 filings
Page 11 of 40
10-K
2018 FY
TGTX
TG Therapeutics Inc
Annual report
1 Mar 19
12:00am
424B5
TGTX
TG Therapeutics Inc
28 Feb 19
Prospectus supplement for primary offering
4:02pm
8-K
TGTX
TG Therapeutics Inc
28 Feb 19
Other Events
7:33am
SC 13G
Ra Capital Management, LLC
14 Feb 19
TG Therapeutics, Inc.
5:14pm
SC 13G
STT
State Street Corp.
14 Feb 19
TG Therapeutics, Inc.
8:42am
SC 13G
TGTX
TG Therapeutics Inc
14 Feb 19
TG Therapeutics, Inc.
8:22am
SC 13G/A
TGTX
TG Therapeutics Inc
14 Feb 19
TG Therapeutics, Inc.
12:00am
SC 13G/A
TGTX
TG Therapeutics Inc
13 Feb 19
TG Therapeutics, Inc.
12:06pm
SC 13G
BLK
Blackrock Inc.
8 Feb 19
TG Therapeutics, Inc.
12:00am
8-K
TGTX
TG Therapeutics Inc
22 Jan 19
Breakthrough Therapy Designation granted based on interim data from the Marginal Zone Lymphoma cohort of the UNITY-NHL trial
8:07am
4
TGTX
TG Therapeutics Inc
3 Jan 19
TG THERAPEUTICS / Sean A Power ownership change
7:21pm
8-K
TGTX
TG Therapeutics Inc
4 Dec 18
Other Events
7:36am
10-Q
2018 Q3
TGTX
TG Therapeutics Inc
Quarterly report
9 Nov 18
4:01pm
8-K
TGTX
TG Therapeutics Inc
9 Nov 18
TG Therapeutics, Inc. Provides Business Update and Reports Third Quarter 2018 Financial Results
7:35am
8-K
TGTX
TG Therapeutics Inc
15 Oct 18
TG Therapeutics, Inc. Announces Final Phase 2 Multiple Sclerosis Data Presentation at the 34th Congress of ECTRIMS
5:20pm
8-K
TGTX
TG Therapeutics Inc
25 Sep 18
TG Therapeutics Announces Update Regarding UNITY-CLL Phase 3 Trial
7:15am
CT ORDER
TGTX
TG Therapeutics Inc
18 Sep 18
Confidential treatment order
12:00am
10-Q
2018 Q2
TGTX
TG Therapeutics Inc
Quarterly report
9 Aug 18
12:00am
8-K
TGTX
TG Therapeutics Inc
7 Aug 18
Results of Operations and Financial Condition
12:00am
EFFECT
TGTX
TG Therapeutics Inc
24 Jul 18
Notice of effectiveness
12:15am